influenza
publication date
Covid-19
Health Workers Warn Loosening Mask Advice in Hospitals Would Harm Patients and Providers
A CDC draft controversially concludes that N95 face masks are equivalent to looser, surgical face masks in certain settings.
Pharma
IRA-mandated Free Vax Could Save Seniors More Than $230M
As of January 1, vaccines are now free under Medicare Part D, and include vaccines for Tdap and shingles.
Pharma
A Technicality Could Keep RSV Shots From Kids in Need
The CDC is now assessing whether nirsevimab would be eligible for the Vaccines for Children program.
Covid-19
FDA Experts Are Still Puzzled Over Who Should Get Which COVID Shots and When
Panel disagrees with FDA proposal that everyone get at least one shot a year, saying more information is needed.
Pharma
What Older Americans Need to Know About Taking Paxlovid
Seek treatment with antiviral therapy, which remains effective against new COVID variants.
Pharma
Bernie Blasts 'Unacceptable Corporate Greed' As Moderna Mulls 4X Price Hike for COVID Vax
Quadrupling the price of COVID-19 vaccine would make it too expensive for millions of Americans, the Vermont Independent says.
Covid-19
Medicare Keeps Spending More on COVID-19 Testing. Fraud and Overspending Are Partly Why.
Medicare's COVID-19 testing costs reached over $2 billion in 2022. The growing costs concern some experts, who say financial incentives...
Clinical Care
Flu Patients at Risk of Developing Sepsis
Sepsis can develop as the result of any kind of infection, including influenza.
Payer
Paxlovid has been free so far. Next year, sticker shock awaits.
The U.S. government has so far purchased 20 million courses of Paxlovid, priced at about $530 each.
Covid-19
Researchers Link 266K Avertable Deaths to COVID Vaccination Rates
The U.S. saw 111 deaths per 100,000 population, more than double the COVID mortality rate of other wealthy nations.
Covid-19
Paxlovid rebound raises questions, but studies have answers
Biden's rebound is far from the first, although they are reportedly "rare."
Pharma
FDA Authorizes Second COVID-19 Vaccine Booster
The space has become increasingly controversial, with varying new recommendations.